Log In
Print this Print this

Trivalent seasonal influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company Novavax Inc.
DescriptionTrivalent seasonal influenza vaccine using virus-like particle (VLP) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against seasonal influenza virus
Regulatory Designation
Partner Cadila Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today